Genomics

Dataset Information

0

Ena-DATASET-DKFZ-HIPO-01-12-2017-13:02:22:609-63 - samples

ABSTRACT: This dataset contains paired fastq files for LMS tumor samples

PROVIDER: EGAD00001003828 | EGA |

REPOSITORIES: EGA

Json Xml
altmetric image

Publications

Integrative genomic and transcriptomic analysis of leiomyosarcoma.

Chudasama Priya P   Mughal Sadaf S SS   Sanders Mathijs A MA   Hübschmann Daniel D   Chung Inn I   Deeg Katharina I KI   Wong Siao-Han SH   Rabe Sophie S   Hlevnjak Mario M   Zapatka Marc M   Ernst Aurélie A   Kleinheinz Kortine K   Schlesner Matthias M   Sieverling Lina L   Klink Barbara B   Schröck Evelin E   Hoogenboezem Remco M RM   Kasper Bernd B   Heilig Christoph E CE   Egerer Gerlinde G   Wolf Stephan S   von Kalle Christof C   Eils Roland R   Stenzinger Albrecht A   Weichert Wilko W   Glimm Hanno H   Gröschel Stefan S   Kopp Hans-Georg HG   Omlor Georg G   Lehner Burkhard B   Bauer Sebastian S   Schimmack Simon S   Ulrich Alexis A   Mechtersheimer Gunhild G   Rippe Karsten K   Brors Benedikt B   Hutter Barbara B   Renner Marcus M   Hohenberger Peter P   Scholl Claudia C   Fröhling Stefan S  

Nature communications 20180110 1

Leiomyosarcoma (LMS) is an aggressive mesenchymal malignancy with few therapeutic options. The mechanisms underlying LMS development, including clinically actionable genetic vulnerabilities, are largely unknown. Here we show, using whole-exome and transcriptome sequencing, that LMS tumors are characterized by substantial mutational heterogeneity, near-universal inactivation of TP53 and RB1, widespread DNA copy number alterations including chromothripsis, and frequent whole-genome duplication. Fu  ...[more]

Similar Datasets

Unknown HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure.
| S-EPMC8100314 | biostudies-literature
Unknown Two tagging single-nucleotide polymorphisms to capture HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 haplotype associated with asparaginase hypersensitivity.
| S-EPMC8247313 | biostudies-literature
Genomics Phialemonium globosum strain:LMS 16-13
| PRJNA1360844 | ENA
Unknown HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia.
| S-EPMC5685222 | biostudies-literature
Unknown HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-Related Membranous Nephropathy.
| S-EPMC5407724 | biostudies-literature
Unknown HLA-B*46:01:01:01 and HLA-DRB1*09:01:02:01 are associated with anti-rHuEPO-induced pure red cell aplasia.
| S-EPMC10733298 | biostudies-literature
Unknown HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression.
| S-EPMC4806662 | biostudies-literature
Unknown Naturally processed non-canonical HLA-A*02:01 presented peptides.
| S-EPMC4317018 | biostudies-literature
Unknown Identification of HLA-A*11:01 and A*02:01-Restricted EBV Peptides Using HLA Peptidomics.
| S-EPMC11125987 | biostudies-literature
Proteomics C1R.A*01:01, C1R.A*02:01, C1R.A*24:02 MHC class I immunopeptidome LC-MSMS
2020-07-27 | PXD014754 | Pride